This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Quant Picks: 4 Pharmaceutical Companies to Add to Your Porfolio

8/05/15 8:30 AM EDT
With Shire offering to acquire Baxalta for more than $30 billion, we decided to check TheStreet Quant Ratings for stocks in the pharmaceuticals sub-sector that would be good investments. Baxalta manufactures drugs which treat rare diseases. Some of the diseases those drugs help treat are for immune deficiencies and rare bleeding disorders. Shire is based in Dublin, and it is using its tax-friendly prominence to acquire a U.S. based company. It is a bio-pharmaceutical company that researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. Investors have benefited from the abundance of mergers and acquisitions in the industry this year. Pharmaceutical company deals are motivated by the desire to beef up the new drug pipeline and streamline heavy research costs. Here are some of the best pharmaceuticals our algorithm says you should consider looking at. Number 4 is Pfizer. With an 'A-' rating, the company's strengths can be seen in its solid stock price performance and expanding profit margins. 3rd is, Novartis AG. This rating is also an 'A-.' Novartis thrives in its solid stock price performance and expanding profit margins. 2nd is Johnson and Johnson. This too has an 'A-' rating. The company flourishes in its increase in net income and expanding profit margins. Number 1 is Novo Nordisk. With an 'A' rating, the company's strengths can be seen in its increase in net income and notable return on equity. TheStreet Ratings are algorithmic stock picks based on 32 major data points. S&P 500 stocks rated 'buy' yielded a 16-and-a-half-percent return in 2014, beating the S&P 500 Total Return Index by more than 300 basis points. For the full reports on these stocks, you can check out
Stocks in this video: SHPGBXLTNVOJNJNVSPFE
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs